US2021140955A1PendingUtilityA1
Methods and compositions for enhancing immunoassays
Est. expiryMar 15, 2033(~6.6 yrs left)· nominal 20-yr term from priority
G01N 33/54373G01N 2333/55G01N 2333/5412
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Embodiments of the methods, compositions, and systems provided herein relate to enzymatic enhancement of immunoassays using photonic sensor arrays.
Claims
exact text as granted — not AI-modified1 . A method of detecting interleukin-6 (IL-6) comprising:
(a) obtaining an optical ring resonator having a first anti-cytokine antibody attached thereto, wherein the first anti-cytokine antibody is anti-IL-6 from clone MAB206 antibody; (b) contacting the first anti-cytokine antibody with a sample comprising IL-6 that selectively binds to the anti-cytokine antibody; (c) contacting the bound IL-6 with a second anti-cytokine antibody that selectively binds to the IL-6, wherein the second anti-cytokine antibody is a biotinylated anti-IL-6 from clone BAF206; (d) contacting the biolinylated second anti-cytokine antibody with a streptavidin-horseradish peroxidase conjugate; (e) contacting the horseradish peroxidase with a solution comprising 4-chloro-1-naphthol and hydrogen peroxide, under conditions that oxidize 4-chloro-1-naphthol to 4-chloro-1-naphthon, whereby the 4-chloro-1-naphthon precipitates on the surface of the optical ring resonator; and (f) measuring a change in resonance wavelengths of the optical ring resonator, thereby indicating the presence of the IL-6.
2 . The method of claim 1 , wherein a fluidic cell comprises the optical ring resonator.
3 . The method of claim 1 , wherein step (e) comprises contacting the horseradish peroxidase with a substantially continuous flow of the solution comprising the 4-chloro-1-naphthol and hydrogen peroxide.
4 . The method of claim 3 , wherein the 4-chloro-1-naphthon precipitates on the surface of the optical ring resonator during the substantially continuous flow of the solution.
5 . The method of claim 3 , wherein the substantially continuous flow of the solution is maintained for steps (e) and (f).
6 . The method of claim 3 , wherein the flow rate of the solution is about 30 μL/min.
7 . The method of claim 3 , wherein a continuous flow of the solution is maintained for step (e).
8 . The method of claim 7 , wherein the continuous flow of the solution is maintained for steps (e) and (f).
9 . The method of claim 7 , wherein the flow rate of the solution is about 30 μL/min.
10 . The method of claim 3 , wherein a substantially continuous flow of reagents contacting the optical ring resonator having a first anti-cytokine antibody attached thereto is maintained for each of steps (b), (c), (d), and (e).
11 . The method of claim 10 , wherein the flow rate of the reagents is about 30 μL/min.
12 . The method of claim 3 , wherein a continuous flow of reagents contacting the optical ring resonator having a first anti-cytokine antibody attached thereto is maintained for each of steps (b), (c), (d), and (e).
13 . The method of claim 12 , wherein the flow rate of the reagents is about 30 μL/min.
14 . The method of claim 1 , wherein the concentration of hydrogen peroxide is less than about 0.003%.
15 . The method of claim 1 , wherein a concentration of the IL-6 less than about 100 pg/ml is detected.
16 . A system for detecting interleukin-6 (IL-6) comprising:
an optical ring resonator having a first anti-cytokine antibody attached thereto, wherein the first anti-cytokine antibody is anti-IL-6 from clone MAB206 antibody; a sample comprising IL-6, wherein the IL-6 is selectively bound to the anti-cytokine antibody; a second anti-cytokine antibody selectively bound to the IL-6, wherein the second anti-cytokine antibody is a biotinylated anti-IL-6 from clone BAF206; a streptavidin-horseradish peroxidase conjugate in contact with the biolinylated second anti-cytokine antibody; a solution comprising 4-chloro-1-naphthol and hydrogen peroxide in fluid communication with the horseradish peroxidase, under conditions that oxidize 4-chloro-1-naphthol to 4-chloro-1-naphthon, whereby the 4-chloro-1-naphthon precipitates on the surface of the optical ring resonator; and a detector adapted to measure a change in resonance wavelengths of the optical ring resonator, thereby indicating the presence of the IL-6.
17 . A system for detecting interleukin-2 (IL-2) comprising:
an optical ring resonator having a first anti-cytokine antibody attached thereto, wherein the first anti-cytokine antibody is anti-IL-2 from clone MAB206 antibody; a sample comprising IL-6, wherein the IL-6 is selectively bound to the anti-cytokine antibody; a second anti-cytokine antibody selectively bound to the IL-6, wherein the second anti-cytokine antibody is a biotinylated anti-IL-6 from clone 555051; a streptavidin-horseradish peroxidase conjugate in contact with the biolinylated second anti-cytokine antibody; a solution comprising 4-chloro-1-naphthol and hydrogen peroxide in fluid communication with the horseradish peroxidase, under conditions that oxidize 4-chloro-1-naphthol to 4-chloro-1-naphthon, whereby the 4-chloro-1-naphthon precipitates on the surface of the optical ring resonator; and a detector adapted to measure a change in resonance wavelengths of the optical ring resonator, thereby indicating the presence of the IL-2.Join the waitlist — get patent alerts
Track US2021140955A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.